Hypereosinophilic syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Pemphigus-like hypereosinophilic syndrome with FIP1L1-PDGFRA fusion gene: A challenging and uncommon clinical presentation.
|
31021002 |
2019 |
Hypereosinophilic syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Angioimmunoblastic T-cell lymphoma and hypereosinophilic syndrome with FIP1L1/PDGFRA fusion gene effectively treated with imatinib: A case report.
|
28885361 |
2017 |
Hypereosinophilic syndrome
|
0.600 |
Biomarker
|
disease |
CTD_human |
Hypereosinophilic Syndrome as a Rare Cause of Reversible Biventricular Heart Failure.
|
28347583 |
2017 |
Hypereosinophilic syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Imatinib Treatment in PDGFRA-Negative Childhood Hypereosinophilic Syndrome.
|
26257279 |
2016 |
Hypereosinophilic syndrome
|
0.600 |
Biomarker
|
disease |
BEFREE |
Clinical features predict responsiveness to imatinib in platelet-derived growth factor receptor-alpha-negative hypereosinophilic syndrome.
|
26797802 |
2016 |
Hypereosinophilic syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The purpose of this review is to provide an overview of the differential diagnosis for eosinophilia, to recommend specific steps for the pathologist evaluating blood and bone marrow, and to emphasize 2 important causes of eosinophilia that require specific ancillary tests for diagnosis: myeloproliferative neoplasm with PDGFRA rearrangement and lymphocyte-variant hypereosinophilic syndrome.
|
27684977 |
2016 |
Hypereosinophilic syndrome
|
0.600 |
Biomarker
|
disease |
BEFREE |
Until now there have only been 3 reported cases of pediatric FIP1L1-PDGFRα-positive hypereosinophilic syndromes.
|
23337549 |
2014 |
Hypereosinophilic syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Novel imatinib-sensitive PDGFRA-activating point mutations in hypereosinophilic syndrome induce growth factor independence and leukemia-like disease.
|
21224473 |
2011 |
Hypereosinophilic syndrome
|
0.600 |
Biomarker
|
disease |
BEFREE |
Interstitial deletion involving chromosome 4q12 generates the novel tyrosine kinase fusion protein encoded by FIP1L1-PDGFRA, which is present in many patients previously labelled as having hypereosinophilic syndrome, initially reported in 2003.
|
18256119 |
2008 |
Hypereosinophilic syndrome
|
0.600 |
Biomarker
|
disease |
BEFREE |
A 35-year-old man with FIP1L1-PDGFRA positive hypereosinophilic syndrome and cardiac involvement, was treated with imatinib 100 mg daily.
|
17544504 |
2008 |
Hypereosinophilic syndrome
|
0.600 |
Biomarker
|
disease |
BEFREE |
Our study shows that treatment with mepolizumab, an agent designed to target eosinophils, can result in corticosteroid-sparing for patients negative for FIP1L1-PDGFRA who have the hypereosinophilic syndrome.
|
18344568 |
2008 |
Hypereosinophilic syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The fusion protein between the platelet-derived growth factor receptor alpha (PDGFRalpha, P) gene and the Fip1-like1 (FIP1L1, F) may be identified in 14 to 60% of HES and it indicates a clonal hypereosinophilic syndrome called F/P-positive CEL.
|
17549478 |
2008 |
Hypereosinophilic syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
These may also prove useful for other hypereosinophilic syndromes without PDGFRA or PDGFRB rearrangements.
|
17133098 |
2007 |
Hypereosinophilic syndrome
|
0.600 |
Biomarker
|
disease |
LHGDN |
Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia.
|
17299092 |
2007 |
Hypereosinophilic syndrome
|
0.600 |
Biomarker
|
disease |
LHGDN |
FIP1L1-PDGFRA positive chronic eosinophilic leukemia in Tunisian patients.
|
17137731 |
2007 |
Hypereosinophilic syndrome
|
0.600 |
Biomarker
|
disease |
BEFREE |
Platelet-derived growth factor receptor-alpha-associated hypereosinophilic syndrome and lymphomatoid papulosis.
|
16965435 |
2006 |
Hypereosinophilic syndrome
|
0.600 |
Biomarker
|
disease |
CTD_human |
Apoptosis induction by retinoids in eosinophilic leukemia cells: implication of retinoic acid receptor-alpha signaling in all-trans-retinoic acid hypersensitivity.
|
16778211 |
2006 |
Hypereosinophilic syndrome
|
0.600 |
GeneticVariation
|
disease |
LHGDN |
A clonal hypereosinophilic syndrome with specific and effective therapy: a report of two cases.
|
17214097 |
2006 |
Hypereosinophilic syndrome
|
0.600 |
Biomarker
|
disease |
BEFREE |
Multilineage involvement of the fusion gene in patients with FIP1L1/PDGFRA-positive hypereosinophilic syndrome.
|
16409293 |
2006 |
Hypereosinophilic syndrome
|
0.600 |
Biomarker
|
disease |
LHGDN |
Detection of the FIP1L1-PDGFRA fusion in idiopathic hypereosinophilic syndrome and chronic eosinophilic leukemia.
|
16502585 |
2006 |
Hypereosinophilic syndrome
|
0.600 |
GeneticVariation
|
disease |
LHGDN |
[FIP1L1-PDGFRalpha-positive myeloproliferative disease with hypereosinophilia: clinical characteristics and pathogenetic therapy].
|
16116920 |
2005 |
Hypereosinophilic syndrome
|
0.600 |
Biomarker
|
disease |
BEFREE |
The hypereosinophilic syndrome: fluorescence in situ hybridization detects the del(4)(q12)-FIP1L1/PDGFRA but not genomic rearrangements of other tyrosine kinases.
|
15921374 |
2005 |
Hypereosinophilic syndrome
|
0.600 |
Biomarker
|
disease |
BEFREE |
The discovery of the FIP1L1-PDGFRA fusion gene in the hypereosinophilic syndrome is an example of the power of clinical translational research and identifies interstitial chromosomal deletion as a novel mechanism to generate oncogenic tyrosine kinase fusion genes.
|
14676627 |
2004 |
Hypereosinophilic syndrome
|
0.600 |
GeneticVariation
|
disease |
LHGDN |
A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.
|
12660384 |
2003 |
Hypereosinophilic syndrome
|
0.600 |
CausalMutation
|
disease |
CGI |
|
|
|